Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sight Sciences, Inc.SGHT · Entity 5537 | Chief Commercial Officer | February 09, 2022 | February 11, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sight Sciences, Inc.
Report date February 09, 2022 · Filed February 11, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 18,100 |
Reported balance
After 2022-02-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-02-09 · Grant · Acquired 18,100 · Balance 18,100 F1: Each Restricted Stock Unit represents a contingent right to receive one share of Issuer common stock. F2: The Restricted Stock Units vest as to 25% on each of January 1, 2023; January 1, 2024; January 1, 2025 and January 1, 2026. The Restricted Stock Units have no expiration date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.52 · Expires 2032-02-09 | Direct | 72,300 |
Reported balance
After 2022-02-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-02-09 · Grant · Acquired 72,300 · Balance 72,300 F3: The options vest and become exercisable in 48 substantially equal monthly installments with the first installment vesting on February 1, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents a contingent right to receive one share of Issuer common stock.
F2: The Restricted Stock Units vest as to 25% on each of January 1, 2023; January 1, 2024; January 1, 2025 and January 1, 2026. The Restricted Stock Units have no expiration date.
F3: The options vest and become exercisable in 48 substantially equal monthly installments with the first installment vesting on February 1, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2022 Filed Feb 11, 2022 21:05 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantStock Option (Right to Buy) · Derivative | 72,300 | $0.00 Strike: $17.52 | $0.00 |
DisclosureSEC source: 0000899243-22-005824 · doc4.xml · derivative · entry 2 O'Neil Shawn · CIK 0001870431 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,300 Underlying: Common Stock · 72,300 shares Expires 2032-02-09 F3 · derivative.exercise_date: The options vest and become exercisable in 48 substantially equal monthly installments with the first installment vesting on February 1, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:05 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantRestricted Stock Units · Derivative | 18,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-005824 · doc4.xml · derivative · entry 1 O'Neil Shawn · CIK 0001870431 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,100 Underlying: Common Stock · 18,100 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest as to 25% on each of January 1, 2023; January 1, 2024; January 1, 2025 and January 1, 2026. The Restricted Stock Units have no expiration date. F2 · derivative.expiration_date: The Restricted Stock Units vest as to 25% on each of January 1, 2023; January 1, 2024; January 1, 2025 and January 1, 2026. The Restricted Stock Units have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.